CFM
INSM icon

Catalyst Funds Management’s Insmed INSM Stock Holding History

Catalyst Funds Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-47,900
Closed -$6.9M – 453
2025
Q3 		$6.9M Buy
47,900
+725
+2% +$88.8K 1.04% 17
2025
Q2 		$4.75M Buy
+47,175
New +$3.61M 1.31% 10
2025
Q1 		– Sell
-11,250
Closed -$777K – 522
2024
Q4 		$777K Buy
11,250
+4,250
+61% +$306K 0.19% 110
2024
Q3 		$511K Buy
+7,000
New +$517K 0.11% 131
2024
Q2 		– Sell
-1,600
Closed -$43.4K – 1364
2024
Q1 		$43.4K Buy
+1,600
New +$44.8K 0.01% 597

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Catalyst Funds Management's INSM Position: Q4 2025 in Review

Catalyst Funds Management sold out of Insmed (INSM) in Q4 2025, closing a stake of 47,900 shares — an estimated $6.9M sold.

Catalyst Funds Management first reported a position in INSM in Q1 2024 and held it in 5 quarters. The position peaked at $6.9M in Q3 2025. 676 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

  • Catalyst Funds Management reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
  • Catalyst Funds Management sold 47,900 Insmed shares in Q4 2025, an estimated $6.9M.
  • Catalyst Funds Management first reported a position in Insmed in Q1 2024 and held it in 5 quarters.
  • Catalyst Funds Management's Insmed position peaked at $6.9M in Q3 2025.
  • 676 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Catalyst Funds Management's 13F filing for Q4 2025, filed 9 Feb 2026.